COVID-19 Specific T Cell derived exosomes (TC Erciyes University)

N/A

Report date: 2024/11/22 20:00:28

Base Information

Drug NameCOVID-19 Specific T Cell derived exosomes (TC Erciyes University)
Drug Alias NameCSTC-Exo
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus InfectionsPneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTurkey
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTc Erciyes University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTc Erciyes University
Active IndicationsN/A
Inactive IndicationsCoronavirus InfectionsPneumonia

Other Information

ATC CodeN/A
Related LinksN/A